Successful response to dupilumab in a refractory case of atopic dermatitis-like chronic cutaneous graft-versus-host disease

Therapeutic strategies with proven efficacy for chronic cutaneous graft-versus-host disease (GvHD) are limited, with long-term oral glucocorticoids remaining the first-line treatment. Prolonged treatment with glucocorticoids contributes to the significantly increased risk of nonrelapse mortality and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of dermatology (1951) 2024-03, Vol.190 (4), p.581-583
Hauptverfasser: Tierney, Emma, Evans, Pamela, Broderick, Valerie, Wynn, Robert, Irvine, Alan D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Therapeutic strategies with proven efficacy for chronic cutaneous graft-versus-host disease (GvHD) are limited, with long-term oral glucocorticoids remaining the first-line treatment. Prolonged treatment with glucocorticoids contributes to the significantly increased risk of nonrelapse mortality and substantial deficit in quality of life reported in paediatric transplant patients with chronic GvHD. We report a case of atopic dermatitis-like chronic cutaneous GvHD responding to dupilumab, allowing for the eventual withdrawal of oral glucocorticoids.
ISSN:0007-0963
1365-2133
1365-2133
DOI:10.1093/bjd/ljad526